OpenURL Connection Search

Select item for more details and to access through your institution.

Vancomycin plus Imipenem, Ceftazidime or Ciprofloxacin in Second Line Therapy in Patients with Febrile Neutropenia Not Responding to First Line Therapy.
Published in:
Chemotherapy (0009-3157), 1996, v. 42, n. 2, p. 146, doi. 10.1159/000239434
By:
- Lacka, J.;
- Oravcova, E.;
- Sevcikova, L.;
- Studena, M.;
- Bachanova, V.;
- Kukuckova, E.;
- Spanik, S.;
- Sufliarsky, J.;
- Helpianska, L.;
- Trupl, J.;
- Kunova, A.;
- Vochyanova, I.;
- Sycova, Z.;
- Grey, E.;
- Krčméry, Jr., V.
Publication type:
Article
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 2, p. 197, doi. 10.1038/bmt.2014.259
By:
- Bachanova, V;
- Burns, L J;
- Wang, T;
- Carreras, J;
- Gale, R P;
- Wiernik, P H;
- Ballen, K K;
- Wirk, B;
- Munker, R;
- Rizzieri, D A;
- Chen, Y-B;
- Gibson, J;
- Akpek, G;
- Costa, L J;
- Kamble, R T;
- Aljurf, M D;
- Hsu, J W;
- Cairo, M S;
- Schouten, H C;
- Bacher, U
Publication type:
Article
Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 1, p. 142, doi. 10.1038/bmt.2014.211
By:
- Bachanova, V;
- Cao, Q;
- Ustun, C;
- Kendi, A T K;
- Froelich, J;
- Lazaryan, A;
- Burns, L J
Publication type:
Article
Hematopoietic cell transplantation for Waldenström macroglobulinemia.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 3, p. 330, doi. 10.1038/bmt.2011.105
By:
- Bachanova, V;
- Burns, L J
Publication type:
Article
Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma.
Published in:
Bone Marrow Transplantation, 2009, v. 43, n. 3, p. 237, doi. 10.1038/bmt.2008.313
By:
- Bachanova, V.;
- Brunstein, C. G.;
- Burns, L. J.;
- Miller, J. S.;
- Luo, X.;
- Defor, T.;
- Young, J-Ah;
- Weisdorf, D. J.;
- Tomblyn, M.
Publication type:
Article
Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
Published in:
Bone Marrow Transplantation, 2008, v. 41, n. 5, p. 455, doi. 10.1038/sj.bmt.1705889
By:
- Bachanova, V;
- Weisdorf, D
Publication type:
Article
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.
Published in:
Leukemia (08876924), 2014, v. 28, n. 3, p. 658, doi. 10.1038/leu.2013.253
By:
- Bachanova, V;
- Marks, D I;
- Zhang, M-J;
- Wang, H;
- de Lima, M;
- Aljurf, M D;
- Arellano, M;
- Artz, A S;
- Bacher, U;
- Cahn, J-Y;
- Chen, Y-B;
- Copelan, E A;
- Drobyski, W R;
- Gale, R P;
- Greer, J P;
- Gupta, V;
- Hale, G A;
- Kebriaei, P;
- Lazarus, H M;
- Lewis, I D
Publication type:
Article
Phase 1 trial of Ruxolitinib combined with Nivolumab in patients relapsed/refractory Hodgkin lymphoma after failure of check‐point inhibitor (CPI).
Published in:
Hematological Oncology, 2023, v. 41, p. 582, doi. 10.1002/hon.3164_436
By:
- Bachanova, V.;
- Zak, J.;
- Cao, Q.;
- Maakaron, J.;
- Grzywacz, B.;
- Fletcher, C.;
- Ayyappan, S.;
- Hu, M.;
- Desai, S.;
- Felices, M.;
- Farooq, U.;
- Teijaro, J. R.;
- Kenkre, V. P.
Publication type:
Article
Responses after Allogeneic NK Cell Therapy for Lymphoma: correlative analysis revealed impact of host monocytes and robust T cells tumor trafficking.
Published in:
Hematological Oncology, 2023, v. 41, p. 518, doi. 10.1002/hon.3164_383
By:
- Bachanova, V.;
- Cao, Q.;
- Miller, J.;
- Maakaron, J.;
- Felices, M.;
- Wangen, R.;
- Larson, M.;
- Simantov, R.;
- Mazor, R. D.;
- Tilahun, A.;
- Grzywacz, B.
Publication type:
Article
Efficacy of brentuximab consolidation by metabolic response in an international real‐world cohort of classic Hodgkin lymphoma at high risk for progression after ASCT.
Published in:
Hematological Oncology, 2023, v. 41, p. 361, doi. 10.1002/hon.3164_260
By:
- Desai, S. H.;
- Smith, A.;
- Spinner, M.;
- Sykorova, A.;
- Bachanova, V.;
- Evens, A. M.;
- Goyal, G.;
- Kahl, B.;
- Dorritie, K.;
- Azzi, J.;
- Kenkre, V. P.;
- Chang, C.;
- Michalka, J.;
- Fusco, B.;
- Sumransub, N.;
- Hatic, H.;
- Saba, R.;
- Ibrahim, U.;
- Harris, E. I.;
- Shah, H.
Publication type:
Article
Overall survival in classic Hodgkin lymphoma pts who progress after autologous stem cell transplant in the era of novel agents.
Published in:
Hematological Oncology, 2023, v. 41, p. 366, doi. 10.1002/hon.3164_264
By:
- Desai, S. H.;
- Spinner, M.;
- Evens, A. M.;
- Bachanova, V.;
- Goyal, G.;
- Kahl, B.;
- Dorritie, K.;
- Azzi, J.;
- Kenkre, V. P.;
- Arai, S.;
- Chang, C.;
- Fusco, B.;
- Sumransub, N.;
- Hatic, H.;
- Saba, R.;
- Ibrahim, U.;
- Harris, E. I.;
- Ansell, S. M.;
- Shah, H.;
- Wagner‐Johnston, N.
Publication type:
Article
OLDER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): REAL WORLD (RW) OUTCOMES OF POST‐INDUCTION THERAPY IN THE MODERN ERA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.69_2880
By:
- David, K. A.;
- Sundaram, S.;
- Kim, S.‐H.;
- Vaca, R.;
- Lin, Y.;
- Singer, S.;
- Malecek, M.‐K.;
- Carter, J.;
- Zayac, A.;
- Kim, M. S.;
- Reddy, N.;
- Ney, D.;
- Habib, A.;
- Strouse, C.;
- Graber, J.;
- Bachanova, V.;
- Salman, S.;
- Vendiola, J. A.;
- Hossain, N.;
- Tsang, M.
Publication type:
Article
OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA EXPERIENCING FRONTLINE TREATMENT FAILURE: A MULTICENTER RETROSPECTIVE STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 408, doi. 10.1002/hon.77_2631
By:
- Bond, D.A.;
- Switchenko, J.;
- Maddocks, K.;
- Churnetski, M.;
- Goyal, S.;
- Shanmugasundaram, K.;
- Calzada, O.;
- Kolla, B.;
- Bachanova, V.;
- Gerson, J.;
- Barta, S.;
- Hill, B.;
- Salwaha, Y.;
- Martin, P.;
- Maldonado, E.;
- Gordon, M.;
- Danilov, A.;
- Grover, N.;
- Mathews, S.;
- Burkart, M.
Publication type:
Article
MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR).
Published in:
Hematological Oncology, 2019, v. 37, p. 405, doi. 10.1002/hon.75_2631
By:
- Hill, B.T.;
- Switchenko, J.M.;
- Martin, P.;
- Churnetski, M.C.;
- Sawalha, Y.;
- Goyal, S.;
- Shanmugasundaram, K.;
- Calzada, O.;
- Kolla, B.;
- Bachanova, V.;
- Gerson, J.N.;
- Barta, S.K.;
- Maldonado, E.;
- Gordon, M.;
- Danilov, A.;
- Grover, N.S.;
- Mathews, S.;
- Burkart, M.;
- Karmali, R.;
- Ghosh, N.
Publication type:
Article
INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 505, doi. 10.1002/hon.189_2631
By:
- Jaeger, U.;
- Tam, C.;
- Borchmann, P.;
- McGuirk, J.;
- Holte, H.;
- Waller, E.;
- Jaglowski, S.;
- Andreadis, C.;
- Foley, S.R.;
- Fleury, I.;
- Westin, J.;
- Teshima, T.;
- Mielke, S.;
- Salles, G.;
- Ho, P.J.;
- Izutsu, K.;
- Schuster, S.;
- Bachanova, V.;
- Maziarz, R.;
- Van Besien, K.
Publication type:
Article
CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 308, doi. 10.1002/hon.118_2630
By:
- Bachanova, V.;
- Westin, J.;
- Tam, C.;
- Borchmann, P.;
- Jaeger, U.;
- McGuirk, J.;
- Holte, H.;
- Waller, E.;
- Jaglowski, S.;
- Bishop, M.;
- Andreadis, C.;
- Foley, S.R.;
- Fleury, I.;
- Teshima, T.;
- Mielke, S.;
- Salles, G.;
- Ho, P.J.;
- Izutsu, K.;
- Maziarz, R.;
- Van Besien, K.
Publication type:
Article
OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA EXPERIENCING FRONTLINE TREATMENT FAILURE: A MULTICENTER RETROSPECTIVE STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 408, doi. 10.1002/hon.77_2631
By:
- Bond, D.A.;
- Switchenko, J.;
- Maddocks, K.;
- Churnetski, M.;
- Goyal, S.;
- Shanmugasundaram, K.;
- Calzada, O.;
- Kolla, B.;
- Bachanova, V.;
- Gerson, J.;
- Barta, S.;
- Hill, B.;
- Salwaha, Y.;
- Martin, P.;
- Maldonado, E.;
- Gordon, M.;
- Danilov, A.;
- Grover, N.;
- Mathews, S.;
- Burkart, M.
Publication type:
Article
MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR).
Published in:
Hematological Oncology, 2019, v. 37, p. 405, doi. 10.1002/hon.75_2631
By:
- Hill, B.T.;
- Switchenko, J.M.;
- Martin, P.;
- Churnetski, M.C.;
- Sawalha, Y.;
- Goyal, S.;
- Shanmugasundaram, K.;
- Calzada, O.;
- Kolla, B.;
- Bachanova, V.;
- Gerson, J.N.;
- Barta, S.K.;
- Maldonado, E.;
- Gordon, M.;
- Danilov, A.;
- Grover, N.S.;
- Mathews, S.;
- Burkart, M.;
- Karmali, R.;
- Ghosh, N.
Publication type:
Article
INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 505, doi. 10.1002/hon.189_2631
By:
- Jaeger, U.;
- Tam, C.;
- Borchmann, P.;
- McGuirk, J.;
- Holte, H.;
- Waller, E.;
- Jaglowski, S.;
- Andreadis, C.;
- Foley, S.R.;
- Fleury, I.;
- Westin, J.;
- Teshima, T.;
- Mielke, S.;
- Salles, G.;
- Ho, P.J.;
- Izutsu, K.;
- Schuster, S.;
- Bachanova, V.;
- Maziarz, R.;
- Van Besien, K.
Publication type:
Article
CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 308, doi. 10.1002/hon.118_2630
By:
- Bachanova, V.;
- Westin, J.;
- Tam, C.;
- Borchmann, P.;
- Jaeger, U.;
- McGuirk, J.;
- Holte, H.;
- Waller, E.;
- Jaglowski, S.;
- Bishop, M.;
- Andreadis, C.;
- Foley, S.R.;
- Fleury, I.;
- Teshima, T.;
- Mielke, S.;
- Salles, G.;
- Ho, P.J.;
- Izutsu, K.;
- Maziarz, R.;
- Van Besien, K.
Publication type:
Article
LOW LEVELS OF IMMUNO-SUPPRESSOR CELLS PROMOTE RESPONSES TO A HAPLOIDENTICAL NATURAL KILLER CELL THERAPY AND INDUCE REMISSIONS IN NON-HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 261, doi. 10.1002/hon.2438_130
By:
- Bachanova, V.;
- Sarhan, D.;
- Defor, T.;
- Cooley, S.;
- Panoskaltsis ‐ Mortari, A.
Publication type:
Article
Serum biomarkers TARC and IL-6 predict relapse risk in Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation.
Published in:
Hematological Oncology, 2017, v. 35, p. 323, doi. 10.1002/hon.2439_66
By:
- Bachanova, V.;
- Trottier, B.J.;
- Cao, Q.;
- Weisdorf, D.J.;
- Burns, L.
Publication type:
Article
GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)-AN INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2017, v. 35, p. 27, doi. 10.1002/hon.2437_6
By:
- Schuster, S.J.;
- Bishop, M.R.;
- Tam, C.;
- Waller, E.K.;
- Borchmann, P.;
- Mcguirk, J.;
- Jäger, U.;
- Jaglowski, S.;
- Andreadis, C.;
- Westin, J.;
- Fleury, I.;
- Bachanova, V.;
- Foley, S.R.;
- Ho, P.J.;
- Mielke, S.;
- Holte, H.;
- Anak, O.;
- Pacaud, L.;
- Awasthi, R.;
- Tai, F.
Publication type:
Article

Found: 23